Showing results (1471-1480 of 1,526) with videos related to

Sort By:
Pageof 153
Nature|November 18, 2021
Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccineMakda S Gebre, Susanne Rauch, Nicole Roth, et al.
Cell Reports|July 16, 2020
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in MiceAndrea J Pruijssers, Amelia S George, Alexandra Schäfer, et al.
Iscience|July 25, 2022
Potent and broad neutralization of SARS-CoV-2 variants of concern (VOCs) including omicron sub-lineages BA.1 and BA.2 by biparatopic human VH domainsChuan Chen, James W Saville, Michelle M Marti, et al.
BMC Health Services Research|June 3, 2021
Comparing models of delivery for cancer genetics services among patients receiving primary care who meet criteria for genetic evaluation in two healthcare systems: BRIDGE randomized controlled trialKimberly A Kaphingst, Wendy Kohlmann, Rachelle Lorenz Chambers, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2022
Potent Neutralization of Omicron and other SARS-CoV-2 Variants of Concern by Biparatopic Human VH DomainsChuan Chen, James W Saville, Michelle M Marti, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Remdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in miceAndrea J Pruijssers, Amelia S George, Alexandra Schäfer, et al.
Cell Reports|April 23, 2024
Mapping of susceptibility loci for Ebola virus pathogenesis in miceAlexandra Schäfer, Andrea Marzi, Wakako Furuyama, et al.
Cell Reports. Medicine|May 31, 2021
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functionsAndrea R Shiakolas, Kevin J Kramer, Daniel Wrapp, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Targetable treatment resistance in thyroid cancer with clonal hematopoiesisVera Tiedje, Pablo Sánchez Vela, Julie L Yang, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functionsAndrea R Shiakolas, Kevin J Kramer, Daniel Wrapp, et al.
Pageof 153